Risk factors for antepartum venous thromboembolism in pregnant people with sickle cell disease

Sickle cell disease (SCD) is a thrombophilia exacerbated by pregnancy. However, there is not strong evidence for thromboprophylaxis, perhaps because most data addressing pregnancy-related thrombosis in SCD is limited by derivation from administrative datasets. We studied venous thromboembolism (VTE) in a retrospective cohort of pregnant people with SCD who delivered singleton pregnancies at two academic centres between 1990 and 2021. Among 289 pregnancies to 197 SCD subjects, 6% had VTE. We compared characteristics of the first study pregnancy in which a VTE occurred (cases) to the first study pregnancy in subjects without pregnancy-related VTE (controls). Preconception complications associated with VTE were history of VTE (cases: 33% [n = 5/15] vs. controls: 4% [n = 7/182], p < 0.001), acute chest syndrome (ACS) (80% [n = 12/15] vs. 37% [n = 68/182], p = 0.001) and acute care for vaso-occlusive crisis (VOC) in the year before pregnancy (80% [n = 12/15] vs. 43% [n = 70/182], p = 0.006). Prenatal complications associated with VTE were ACS (47% [n = 7/15] vs. 10% [n = 19/182], p < 0.001) and VOC (93% [n = 14/15] vs. 65% [n = 119/182], p = 0.026). Fetal outcomes associated with VTE included gestational age at delivery (median [IQR] 37.0 [34.0-38.1] weeks vs. 38.3 [36.9-39.3], p = 0.004). Studies are needed to establish interventions that attenuate VTE risk and define prophylactic anti-coagulation parameters for this high-risk population.

Authors

Institutions

Publication Details

Journal
British Journal of Haematology
Published
2026-11-16
DOI
https://doi.org/10.1111/bjh.70943
Primary Topic
Hemoglobinopathies and Related Disorders
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Risk factors for antepartum venous thromboembolism in pregnant people with sickle cell disease

Rakhi P P. Naik, Lydia H. Pecker, Gloria Frances Gerber, Ann Kinga Malinowski et al.
2 links
British Journal of Haematology
Hemoglobinopathies and Related Disorders
article

Risk factors for antepartum venous thromboembolism in pregnant people with sickle cell disease

Rakhi P P. Naik, Lydia H. Pecker, Gloria Frances Gerber, Ann Kinga Malinowski, Nadine Shehata, Kevin H.M. Kuo, Macy L. Early, Jayla Lynn Scott, Michael Blake Streiff, Vinal Menon, Sacha Choupa, Amy Luo
article en

Abstract

Sickle cell disease (SCD) is a thrombophilia exacerbated by pregnancy. However, there is not strong evidence for thromboprophylaxis, perhaps because most data addressing pregnancy-related thrombosis in SCD is limited by derivation from administrative datasets. We studied venous thromboembolism (VTE) in a retrospective cohort of pregnant people with SCD who delivered singleton pregnancies at two academic centres between 1990 and 2021. Among 289 pregnancies to 197 SCD subjects, 6% had VTE. We compared characteristics of the first study pregnancy in which a VTE occurred (cases) to the first study pregnancy in subjects without pregnancy-related VTE (controls). Preconception complications associated with VTE were history of VTE (cases: 33% [n = 5/15] vs. controls: 4% [n = 7/182], p < 0.001), acute chest syndrome (ACS) (80% [n = 12/15] vs. 37% [n = 68/182], p = 0.001) and acute care for vaso-occlusive crisis (VOC) in the year before pregnancy (80% [n = 12/15] vs. 43% [n = 70/182], p = 0.006). Prenatal complications associated with VTE were ACS (47% [n = 7/15] vs. 10% [n = 19/182], p < 0.001) and VOC (93% [n = 14/15] vs. 65% [n = 119/182], p = 0.026). Fetal outcomes associated with VTE included gestational age at delivery (median [IQR] 37.0 [34.0-38.1] weeks vs. 38.3 [36.9-39.3], p = 0.004). Studies are needed to establish interventions that attenuate VTE risk and define prophylactic anti-coagulation parameters for this high-risk population.

British Journal of Haematology
Meharry Medical College (US), Mount Sinai Hospital (CA), University Health Network (CA), Johns Hopkins University (US), University of Toronto (CA), Johns Hopkins Medicine (US), Sinai Health System (CA), University of Pennsylvania Health System (US), Hamilton Health Sciences (CA), McMaster University (CA)
Foundation for Women and Girls with Blood Disorders, National Heart, Lung, and Blood Institute, National Institute of Mental Health, Office of Women's Health
Good health and well-being
Hemoglobinopathies and Related Disorders
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon